EDESA BIOTECH, INC.: 10-Q filed 2017-08-09

Name: EDESA BIOTECH, INC.: 10-Q filed 2017-08-09
Creator: EDESA BIOTECH, INC.

What EDESA BIOTECH, INC. reported in its quarterly report filed 2017-08-09 (fiscal Q3 2017): 24 published measures, 66 facts as tagged in accession 0001144204-17-041718.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-09
Fiscal period: fiscal Q3 2017
Accession: 0001144204-17-041718 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-06-30	9,022,272	USD
At 2016-09-30	12,937,804	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-06-30	8,596,930	USD
At 2016-09-30	12,314,160	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-06-30	3,647,363	USD
At 2016-09-30	7,416,904	USD
At 2016-06-30	4,787,203	USD
At 2015-09-30	3,955,503	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,220,361	USD	91
2016-10-01 to 2017-06-30	-3,809,710	USD	273
2016-04-01 to 2016-06-30	-1,194,077	USD	91
2015-10-01 to 2016-06-30	-3,684,890	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	200,365	USD	273
2015-10-01 to 2016-06-30	294,858	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	20,532	USD	91
2016-10-01 to 2017-06-30	225,407	USD	273
2016-04-01 to 2016-06-30	181,092	USD	91
2015-10-01 to 2016-06-30	995,587	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-06-30	-44,171,105	USD
At 2016-09-30	-40,361,395	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	0	USD	91
2016-10-01 to 2017-06-30	800	USD	273
2016-04-01 to 2016-06-30	0	USD	91
2015-10-01 to 2016-06-30	7,200	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-06-30	820,888	USD
At 2016-09-30	756,114	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	92,480	USD	273
2015-10-01 to 2016-06-30	209,781	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,293,616	USD	91
2016-10-01 to 2017-06-30	-3,855,649	USD	273
2016-04-01 to 2016-06-30	-1,188,478	USD	91
2015-10-01 to 2016-06-30	-3,591,775	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-06-30	8,119,349	USD
At 2016-09-30	12,099,655	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-06-30	425,342	USD
At 2016-09-30	623,644	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	1,314,148	USD	91
2016-10-01 to 2017-06-30	4,081,056	USD	273
2016-04-01 to 2016-06-30	1,369,570	USD	91
2015-10-01 to 2016-06-30	4,587,362	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2017-06-30	140,947	USD
At 2016-09-30	249,430	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	536,169	USD	91
2016-10-01 to 2017-06-30	1,326,405	USD	273
2016-04-01 to 2016-06-30	470,097	USD	91
2015-10-01 to 2016-06-30	1,068,008	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-06-30	10,520,096	shares
At 2016-09-30	10,136,258	shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-06-30	924,578	USD
At 2016-09-30	793,057	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	635,716	USD	91
2016-10-01 to 2017-06-30	2,314,143	USD	273
2016-04-01 to 2016-06-30	720,421	USD	91
2015-10-01 to 2016-06-30	2,595,176	USD	274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	135,515	USD	273
2015-10-01 to 2016-06-30	106,712	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	73,255	USD	91
2016-10-01 to 2017-06-30	46,739	USD	273
2016-04-01 to 2016-06-30	-5,599	USD	91
2015-10-01 to 2016-06-30	-85,915	USD	274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	800	USD	273
2015-10-01 to 2016-06-30	7,200	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	-73,906	USD	273
2015-10-01 to 2016-06-30	-148,611	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-10-01 to 2017-06-30	-108,483	USD	273
2015-10-01 to 2016-06-30	11,418	USD	274

Inspect the source

Entity: EDESA BIOTECH, INC. / CIK 0001540159
Captured: 2026-09-20T09:17:32.413Z
SEC response SHA-256: 0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))